Cite

HARVARD Citation

    Simões, E. et al. (2021). Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants. Clinical infectious diseases. pp. e4400-e4408. [Online]. 
  
Back to record